scispace - formally typeset
S

Sabine A. Eming

Researcher at University of Cologne

Publications -  157
Citations -  12421

Sabine A. Eming is an academic researcher from University of Cologne. The author has contributed to research in topics: Wound healing & Inflammation. The author has an hindex of 43, co-authored 141 publications receiving 9897 citations. Previous affiliations of Sabine A. Eming include Harvard University & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Wound repair and regeneration: Mechanisms, signaling, and translation

Sabine A. Eming, +3 more
- 03 Dec 2014 - 
TL;DR: In this review, emerging concepts in tissue regeneration and repair are highlighted, and some perspectives on how to translate current knowledge into viable clinical approaches for treating patients with wound-healing pathologies are provided.
Journal ArticleDOI

Inflammation in wound repair: molecular and cellular mechanisms.

Sabine A. Eming, +3 more
- 01 Mar 2007 - 
TL;DR: Cellular and molecular mechanisms controlling inflammation in cutaneous tissue repair are reviewed and a rationale for targeting the inflammatory phase in order to modulate the outcome of the healing response is provided.
Journal ArticleDOI

Differential Roles of Macrophages in Diverse Phases of Skin Repair

Tina Lucas, +7 more
- 01 Apr 2010 - 
TL;DR: The results demonstrate that macrophages exert distinct functions during the diverse phases of skin repair, which are crucial to control the natural sequence of repair events.
Journal ArticleDOI

Inflammation and metabolism in tissue repair and regeneration

Sabine A. Eming, +4 more
- 09 Jun 2017 - 
TL;DR: The current understanding of the role of inflammation and cell metabolism in tissue-regenerative responses is reviewed, emerging concepts that may expand therapeutic perspectives are highlighted, and where important knowledge gaps remain are discussed.
Journal ArticleDOI

Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing

Mikaël M. Martino, +9 more
- 14 Sep 2011 - 
TL;DR: Preclinical demonstrations in rodent models show promise for the use of the FN III9-10/12-14–modified matrices in humans to heal chronic wounds and repair bones, and shows potent synergistic signaling and morphogenesis between α5β1 integrin and the growth factor receptors.